HPy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HPy, covering 2026-03-06 to 2026-03-06. Get the full timeline:
Most recent: Clinical Trial Update: A Study on the Efficacy and Safety of Switching Between Two Targeted Strategies, HP+Chemotherapy and HPy+Chemotherapy, After Treatment Progression in HER-2 Positive Advanced or Metastatic Breast Cancer